Evidence map›Paper›PMID 35327350›Full record

ArticleBiomedicines2022

The Role of Genetic Factors in the Development of Acute Respiratory Viral Infection COVID-19: Predicting Severe Course and Outcomes.

Mikhail M Minashkin, Nataliya Y Grigortsevich, Anna S Kamaeva, Valeriya V Barzanova, Alexey A Traspov, Mikhail A Godkov, Farkhad A Ageev, Sergey S Petrikov, Nataliya V Pozdnyakova

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Frontiers in immunology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Genetic variants inFrontiers in genetics · 2025
    Article
  7. Analyses of haplotypes ofFrontiers in genetics · 2025
    Article
  8. Frontiers in immunology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Polymorphisms inGenes · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Mikhail M MinashkinSistema BioTech LLC, 109235 Moscow, Russia.ORCID 0000-0002-0726-7563
Nataliya Y GrigortsevichSistema BioTech LLC, 109235 Moscow, Russia.
Anna S KamaevaSistema BioTech LLC, 109235 Moscow, Russia.
Valeriya V BarzanovaSistema BioTech LLC, 109235 Moscow, Russia.
Alexey A TraspovSistema BioTech LLC, 109235 Moscow, Russia.
Mikhail A GodkovClinical Laboratory, N.V. Sklifosovsky Scientific Research Institute of Emergency Medicine, 129010 Moscow, Russia.
Farkhad A AgeevClinical Laboratory, Moscow City Clinical Hospital #40, 129301 Moscow, Russia.
Sergey S PetrikovClinical Laboratory, N.V. Sklifosovsky Scientific Research Institute of Emergency Medicine, 129010 Moscow, Russia.
Nataliya V PozdnyakovaSistema BioTech LLC, 109235 Moscow, Russia.
Sistema (Russia) · RUResearch Institute of Emergency Care · RUCity Clinical Hospital · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to identify single nucleotide variants in genes associated with susceptibility to or severe outcomes of COVID-19. A total of 319 genomic DNA samples from patients with varying degrees of disease severity and 78 control DNA samples from people who had regular or prolonged contact with patients with COVID-19 but did not have clinical manifestations and/or antibodies to SARS-CoV-2. Seven SNPs were identified that were statistically associated with disease risk or severe course, rs1799864 in the

Indexed as

antiviral immunityCOVID-19genetic variantheavinessSARS-CoV-2single nucleotide polymorphismsusceptibility

Identifiers

PMID35327350
PMCPMC8945420
OpenAlexW4214543955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.